All Stories

  1. Dementia and the heart failure patient
  2. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table
  3. Do we need a reference standard for the muscle mass measurements?
  4. Iron deficiency in chronic heart failure: case-based practical guidance
  5. Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity: reply
  6. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study
  7. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association
  8. Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
  9. Sleep‐Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction
  10. Cardiac muscle wasting in individuals with cancer cachexia
  11. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
  12. Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
  13. Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation
  14. Protective overweight in cardiovascular disease: the obesity paradigm
  15. Insulin resistance in HFrEF and HFpEF
  16. Präoperative Evaluierung vor nicht-kardiochirurgischen Eingriffen
  17. Insulin resistance relates to muscle strength in HF
  18. Stroke-Related Sarcopenia: Specific Characteristics
  19. Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
  20. BMI and mortality in stroke
  21. Metabolic Impairment in Heart Failure
  22. Muscle Wasting in Patients with Heart Failure with Preserved Ejection Fraction and Its Impact on Muscle Strength and Functional Capacity during Exercise
  23. Stroke induced Sarcopenia: Muscle wasting and disability after stroke
  24. Increased catabolic activity in adipose tissue of patients with chronic heart failure
  25. Overweight, Obesity, and All-Cause Mortality
  26. Obesity and improved outcome after stroke
  27. When a reference value makes all the difference
  28. Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure
  29. Cardiac Cachexia in Chronic Heart Failure: The Metabolic Facet of CHF
  30. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
  31. Xanthine Oxidase Inhibitors and Insulin Sensitizers
  32. Xanthine Oxidase Inhibitors and Insulin Sensitizers
  33. Impaired Insulin Sensitivity as an Independent Risk Factor for Mortality in Patients With Stable Chronic Heart Failure
  34. Uric acid in chronic heart failure
  35. Historic Views on Cachexia in Humans with Special Reference to Cardiac Cachexia